|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| (Loss) profit for the year | |||||
| Adjustments to reconcile net profit to net cash provided by operating activities: | |||||
| Income tax expense | |||||
| Depreciation and amortization | |||||
| Finance income | |||||
| Finance costs | |||||
| Exchange differences | |||||
| Impairment loss | |||||
| Share-based compensation | |||||
| Other (gain) loss | |||||
| Write downs of inventories to net realizable value | |||||
| Change in fair value of derivatives not designated as hedging instruments | |||||
| Changes in operating assets and liabilities: | |||||
| Decrease (increase) in inventories | |||||
| Decrease (increase) in trade and other receivables | |||||
| Decrease (increase) in trade receivables | |||||
| Decrease (increase) in other receivables | |||||
| Decrease (increase) in energy receivable | |||||
| (Decrease) increase in trade payables | |||||
| Other changes in operating assets and liabilities | |||||
| Income taxes paid | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Interest and finance income received | |||||
| Payments due to investments: | |||||
| Intangible assets | |||||
| Property, plant and equipment | |||||
| Other financial assets | |||||
| Disposals: | |||||
| Other non-current assets | |||||
| Receipt of asset-related government grant | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Dividends paid | |||||
| Payment for debt and equity issuance costs | |||||
| Repayment of debt instruments | |||||
| Proceeds from debt issuance | |||||
| Increase (decrease) in bank borrowings: | |||||
| Borrowings | |||||
| Payments | |||||
| Payments for lease liabilities | |||||
| Proceeds from other financing liabilities | |||||
| Other (payments) receipts from financing activities | |||||
| Payments to acquire own shares | |||||
| Interest paid | |||||
| Net cash used in financing activities | |||||
| Total net increase (decrease) in cash and cash equivalents | |||||
| Beginning balance of cash and cash equivalents | |||||
| Foreign exchange (losses) gains on cash and cash equivalents | |||||
| Restricted cash and cash equivalents | |||||
| Cash and cash equivalents | |||||
| Ending balance of cash and cash equivalents | |||||
Loading...